Stock Market Today, Jan. 13: Nvidia Rises on H200 Export Developments

Nvidia closed at $185.81, up 0.47% on Tuesday with volume of 158.40M shares (16.51% below its three‑month average), as Reuters reported the U.S. cleared limited exports of H200 AI chips to China while Chinese authorities said only select local firms will be allowed to use them and U.S. third‑party testing is required. The partial approvals alleviate some near‑term export uncertainty even as Chinese restrictions raise questions about demand durability; peers Advanced Micro Devices and Intel outperformed on the session (AMD +6.39% to $220.97; INTC +7.33% to $47.29) while the S&P 500 and Nasdaq declined modestly. Nvidia also highlighted continued product development with its Vera Rubin data‑center architecture, a factor that supports long‑term AI positioning amid mixed near‑term regulatory risk.

Analysis

Market structure: Short-term winners are Nvidia-approved Chinese buyers and alternate silicon vendors (AMD, INTC) that benefit from investor rotation; NVDA traded at $185.81 (+0.47%) on volume 16.5% below its 3-month avg while AMD and INTC jumped +6.39% and +7.33% respectively. The staged U.S. export approval plus PRC “select buyer” policy points to concentrated demand (fewer customers buying larger lots) which preserves ASPs for approved orders but limits broad TAM conversion over the next 1–3 quarters.

Risk assessment: Tail risks include a renewed U.S. export clampdown or a broader Chinese ban that could remove a meaningful share of NVDA’s addressable China revenue within 30–90 days; operational risk centers on third‑party U.S. testing creating 2–8 week shipping lags. Near-term (days–weeks) expect volatility and order-front‑loading; medium (3–12 months) will be decided by the PRC approved‑buyer list and order cadence; long-term (12–36 months) NVDA’s Vera Rubin roadmap could re-expand TAM if ecosystem adoption continues.

Trade implications: Tactical trades should balance conviction in NVDA’s long-cycle dominance with near-term geopolitical execution risk: use capped long exposure and hedges rather than outright size. Relative-value: favor 3–6 month longs in AMD/INTC (cheaper entry, immediate leverage to AI server demand) vs trimmed NVDA exposure; use short-dated NVDA put‑spreads or covered-call overlays to monetize volatility and protect downside.

Contrarian angles: Consensus underweights concentration benefit—approved customers may pay premium and generate outsized per-customer revenue, so a modest buy-on-weakness swing into NVDA after a >20% drawdown could be optimal. Conversely, if PRC channels spending to domestic accelerators, expect structural share erosion over multiple years—keep a 0.5–1% hedge to Chinese silicon exposure as insurance.

Key Decisions for Investors

• Establish a long-term core NVDA position sized 2–3% of portfolio for 12–36 months, funded by selling 6–9 month covered calls ~10–15% OTM to collect premium and reduce downside; trim if NVDA rallies >15% from current levels or if approvals list expands to >50% of Chinese hyperscalers.
• Initiate a short-dated hedge: buy a 45-day NVDA 180/150 bear put spread sized 0.5–1.0% of portfolio to protect against a China-driven 10–30% drawdown; roll or close after 45 days based on PRC approvals news.
• Deploy a 2% long position in AMD (ticker AMD) for 3–6 months as a relative-value play versus NVDA; offset by a 1% funded short/trim in NVDA exposure or use relative pair swaps, exit if AMD underperforms NVDA by >10% or after 3 months.
• Monitor two binary catalysts over the next 30–60 days: (1) the PRC approved‑buyer list (if >50% of major cloud/hyperscalers approved, add up to +3% NVDA exposure), and (2) formal U.S. testing guidance timelines (if testing delays >30 days, increase hedges and pause new NVDA buys).